Singapore-founded digital therapeutics firm Biofourmis announced raising $300 million in a Series D funding round led by growth equity firm General Atlantic, taking its valuation past the $1 billion mark.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
